Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance

NCT00085982 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

NIH

Sponsor class

Conditions

Severe Insulin Resistance

Interventions

DRUG: Metreleptin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)